Aki Shimotsuka

Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.

T. Ogata, K. Tachibana, Y. Shishiba, 2004, The Journal of clinical endocrinology and metabolism.